Kulkarni Maithili Mandar, Khandeparkar Siddhi Gaurish Sinai, Joshi Avinash R, Dhande Ashish N
Department of Pathology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India.
Indian J Pathol Microbiol. 2016 Apr-Jun;59(2):209-211. doi: 10.4103/0377-4929.182021.
Secretory breast carcinomas (SBCs) are considered one of the rarest types of BCs accounting for <0.15% of all breast cancers. The lesions are typically solitary, but rare multicentric cases have been reported. SBC have characteristic histopathological, immunohistochemical, and electron microscopic findings. Children and adolescents with SBC have a favorable prognosis, but disease seems slightly more aggressive in adults. The characteristic ETV6-NTRK3 molecular alteration, leading to a stable chimeric tyrosine kinase fusion product, may be the target of promising new treatment for this unique BC. We present a rare case of multicentric secretory carcinoma of breast with aggressive clinical behavior in a 75-year-old female.
分泌性乳腺癌(SBC)被认为是最罕见的乳腺癌类型之一,占所有乳腺癌的比例不到0.15%。病变通常为单发,但也有罕见的多中心病例报道。SBC具有特征性的组织病理学、免疫组织化学和电子显微镜检查结果。患有SBC的儿童和青少年预后良好,但在成人中疾病似乎更具侵袭性。特征性的ETV6-NTRK3分子改变导致稳定的嵌合酪氨酸激酶融合产物,可能是针对这种独特乳腺癌的有前景的新治疗靶点。我们报告了一例75岁女性多中心分泌性乳腺癌的罕见病例,其具有侵袭性临床行为。